Clinical & Regulatory Affairs
Didier Coquoz, PhD in clinical pharmacology, is a 30+ years seasoned pharma R&D executive (VP R&D and CEO). He has been instrumental in the development/regulatory management from the candidate status up to phase III studies and registration of close to 30 biologics, monoclonal antibodies, peptides, cell-based therapeutics, NCEs, of which 4 reached the market world-wide, one reaching 1 bio € yearly sales.
He held positions as CEO and VP R&D on both sides of the Atlantic. Since ten years, he is active as a virtual Chief Development and Regulatory Officer for biotech/small pharmas. He operationally designs, implements and manages the manufacturing, toxicology, clinical and regulatory programs in close collaboration with the companies as well as mid-size and large pharmas.